CHP2
Calcineurin B homologous protein 2
Also known as: CHP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43745
- Gene
- CHP2
- Ensembl
- ENSG00000166869
- Chromosome
- 16
- Canonical length
- 196 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene product is a small calcium-binding protein that regulates cell pH by controlling plasma membrane-type Na+/H+ exchange activity. This protein shares sequence similarity with calcineurin B and can bind to and stimulate the protein phosphatase activity of calcineurin A (CnA) and functions in the calcineurin/NFAT (nuclear factor of activated T cells) signaling pathway. Another member of the CHP subfamily, Calcineurin B homologous protein 1, is located on Chromosome 15 and is an inhibitor of calcineurin activity and has a genetic phenotype associated with Parkinson's Disease (OMIM:606988). This gene was initially identified as a tumor-associated antigen and was previously referred to as Hepatocellular carcinoma-associated antigen 520. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
196 residues, UniProt reviewed canonical sequence.
>O43745|CHP2
1 MGSRSSHAAV IPDGDSIRRE TGFSQASLLR LHHRFRALDR NKKGYLSRMD LQQIGALAVN
61 PLGDRIIESF FPDGSQRVDF PGFVRVLAHF RPVEDEDTET QDPKKPEPLN SRRNKLHYAF
121 QLYDLDRDGK ISRHEMLQVL RLMVGVQVTE EQLENIADRT VQEADEDGDG AVSFVEFTKS
181 LEKMDVEQKM SIRILKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 287 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 287 nTPM
- small intestine: 236 nTPM
- skin: 141 nTPM
- rectum: 139 nTPM
- colon: 138 nTPM
- cervix: 13 nTPM
Single-cell type
- enterocytes: 582 nCPM
- colonocytes: 321 nCPM
- enteric transient amplifying cells: 235 nCPM
- enteric stem cells: 136 nCPM
- paneth cells: 93 nCPM
- respiratory secretory cells: 72 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebellum: 18 nTPM
- white matter: 15 nTPM
- hypothalamus: 14 nTPM
- cerebral cortex: 13 nTPM
- pons: 13 nTPM
- basal ganglia: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.68
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to calcium ion
- positive regulation of calcineurin-NFAT signaling cascade
- positive regulation of cell population proliferation
- positive regulation of phosphatase activity
- positive regulation of protein import into nucleus
- positive regulation of transcription by RNA polymerase II
- protein transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHP2 as an antibody target. Whether an autoantibody or antibody against CHP2 could matter depends on whether native CHP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHP2 is annotated at the cell surface, where native CHP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CHP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...